Angiogenic and Inflammatory microRNA Regulation in a Mouse Model of Fetal Growth Restriction

• Published in: The Journal of surgical research 2023-12, Vol.292, p.234-238
• Main Authors: Gallagher, Lauren T., Wright, Clyde J., Lehmann, Tanner, Khailova, Ludmila, Zarate, Miguel, Lyttle, Bailey D., Liechty, Kenneth W., Derderian, S. Christopher
• Format: Article
• Language: English
• Subjects: Angiogenesis; Cytokines; Fetal growth restriction; MicroRNAs
• ISSN: 0022-4804; 1095-8673
• DOI: 10.1016/j.jss.2023.07.052

Fetal growth restriction (FGR) is associated with impaired angiogenesis and chronic inflammation. MicroRNAs (miRs) are short noncoding RNAs that regulate gene expression at the post-transcriptional level by targeting messenger RNA (mRNA) for degradation or by suppressing translation. We hypothesize that dysregulation of miR-15b, an antiangiogenic miR, and miR-146a, an anti-inflammatory miR, are associated with the FGR’s pathogenesis. Pregnant mice were provided ad libitum access to food between E1 and E8. From E9-E18, dams received either a 50% caloric restricted diet (FGR) or continued ad libitum access (controls). Placentas were harvested at E18.5 and total RNA was extracted. Gene expression levels of miRs and mRNAs were compared between FGR and control placentas. Placentas affected by FGR demonstrated increased expression of miR-15b. Vascular endothelial growth factor alpha, which is downregulated in response to increased levels of miR-15b, was suppressed. The anti-inflammatory miR, miR-146a, was downregulated, resulting in upregulation of proinflammatory (IL-6, IL-8, and NFkB1) and oxidative stress (HIF-1α, SOD2, and Nox2) mediators. Aberrant angiogenesis and chronic inflammation seen in FGR appear to be associated with dysregulated miR-15b and miR-146a gene expression, respectively. This observation suggests these miRs play a post-transcriptional regulatory role in FGR, providing an insight into possible therapeutic targets.